POLE and cancer: A recent study also suggested that cells with the V411L mutation may, in fact, take a shorter path to cancer: a germline V411L variant was identified in a pediatric CRC case with an onset at least 10 yr earlier than is typical for carriers of other POLE mutations (Wimmer et al. 2017).